Updated Recommendation from the Advisory Committee on Immunization Practices (ACIP) for Use of 7-Valent Pneumococcal Conjugate Vaccine (PCV7) in Children Aged 24-59 Months Who Are Not Completely Vaccinated

April 2008
MMWR: Morbidity & Mortality Weekly Report;4/4/2008, Vol. 57 Issue 13, p343
The article discusses the updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for use of seven-valent pneumococcal conjugate vaccine (PCV7) in children aged 24-59 months. The said vaccine, is marketed as Prevnar and manufactured by Wyeth Vaccines and was approved by the Food and Drug Administration for infants and young children. The recommendation provided schedules for administering the drug to children who are only undervaccinated.


Related Articles

  • Prevnar case study.  // Prevnar: the First Vaccine Blockbuster;Jan2008, p1 

    • The clinical impact of Prevnar on the incidence of invasive pneumococcal disease in the US was enormous. Before the launch of the vaccine, the overall incidence of invasive pneumococcal in the US was estimated to be approximately 188 cases per 100,000 young children aged less than 2...

  • 2010 immunization schedules released.  // Infectious Diseases in Children;Jan2010, Vol. 23 Issue 1, p23 

    The article reports on the changes in the recommended immunization schedules for and the catch-up immunization schedule for 2010, which had been approved several organizations, including the U.S. Advisory Committee on Immunization Practices.

  • Impact of 2-Dose Vaccination on Varicella Epidemiology: Connecticut-2005-2008. Kattan, Jessica A.; Sosa, Lynn E.; Bohnwagner, Heather D.; Hadler, James L. // Journal of Infectious Diseases;2/1/2011, Vol. 203 Issue 3, p509 

    In 2006, the Advisory Committee on Immunization Practices recommended that children routinely receive 2 varicella vaccine doses in place of the 1 dose previously recommended. This recommendation's initial impact on varicella epidemiology in Connecticut was assessed. Reported incidence and...

  • Your guide to the new pneumococcal vaccine for children. Campos-Outcalt, Doug // Journal of Family Practice;Jul2010, Vol. 59 Issue 7, p394 

    The article focuses on the 13-valent pneumococcal conjugate vaccine (PCV13) which is to replace the PCV7 (Prevnar) for the prevention of invasive pneumococcal disease (IPD) in children. It says that though IPD declined in the U.S. with the introduction of PCV7, the incidence of disease caused by...

  • Revised Tdap recommendations seek to improve suboptimal coverage. Sheffer, Joe // Pharmacy Today;Feb2011, Vol. 17 Issue 2, p30 

    The article offers updates related to immunization in the U.S. The Advisory Committee on Immunization Practices (ACIP) has recommended three expanded uses of the tetanus-diphtheria-accellular pertussis (Tdap) to improve suboptimal vaccination coverage. The adults 65 years or older should receive...

  • ACIP Members Express Preference for Combination vs. Component Vaccines.  // American Family Physician;8/1/2009, Vol. 80 Issue 3, p221 

    The article reports on the provisional recommendations of the U.S. Center for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) expressed in a meeting. A statement about the preference for combination vaccines over separate injections of equivalent...

  • ACIP recommends combined immunization schedule for 2013.  // Infectious Diseases in Children;Nov2012, Vol. 25 Issue 11, p1 

    The article reports on unanimous vote of the U.S. Advisory Committee on Immunization Practices (ACIP) to recommend the proposed combined pediatric immunization schedule of the Centers for Disease Control and Prevention (CDC) for 2013.

  • Use of MenACWY-CRM Vaccine in Children Aged 2 Through 23 Months at Increased Risk for Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices, 2013. MacNeil, Jessica R.; Rubin, Lorry; McNamara, Lucy; Briere, Elizabeth C.; Clark, Thomas A.; Cohn, Amanda C. // MMWR: Morbidity & Mortality Weekly Report;6/20/2014, Vol. 63 Issue 24, p527 

    The article provides information on the recommendation by the U.S. Advisory Committee on Immunization Practices (ACIP) during its October 2013 meeting to use a third meningococcal conjugate vaccine in children aged 2-23 months who are at increased risk for meningococcal disease. Topics discussed...

  • ACIP Releases 2015 Childhood Immunization Schedules.  // American Family Physician;2/15/2015, Vol. 91 Issue 4, following p242 

    The article discusses the U.S. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices' (ACIP) recommended immunization schedule for children in 2015. Topics discussed include the recommended use of the quadrivalent live attenuated influenza vaccine (LAIV)...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics